Public Board of Directors papers 29.09.22

Public meeting of the Board of Directors Thursday 30 th June at 12.45 pm Trust meeting room 6 and through virtual access

Present: Chair: Chris Outram (CO), Chairman

Roger Spencer (RS), Chief Executive Officer Dr Jane Maher (JM), Non-executive Director Robert Ainsworth (RA), Non-executive Director Prof Kieran Walshe (KW), Non-executive Director Grenville Page (GP), Non-executive Director Alveena Malik (AM), Non-executive Director Tarun Kapur (TK), Non-executive Director Prof Fiona Blackhall (FB), Director of Research Prof Chris Harrison (CJH), Medical Director and Deputy CEO Bernie Delahoyde (BD), Chief Operating Officer Eve Lightfoot (EL), Director of Workforce Prof Janelle Yorke (JY), Executive Chief Nurse Dr Neil Bayman (NB), Executive Medical Director Sally Parkinson (SP), Interim Director of Finance Prof Richard Fuller (RF), Director of Education

Minutes: Louise Westcott (LW), Company Secretary In attendance: Jo D’Arcy, Assistant Company Secretary

Clinical presentation: MR Linac, Professor Ananya Choudhury, Honorary Academic Consultant & Cynthia Eccles, Consultant Research Radiographer CO welcomed AC to the meeting. AC outlined what MR Linac radiotherapy is about and how treatment has developed. The use of anatomical markers was how radiotherapy was initially targeted, clinicians then moved on to the use of low energy x-ray and from there to cone beam CT, a low dose CT scan. MR imaging is a step up from CT and they give more information. The images are much clearer. If we could have this clarity when giving radiotherapy this would be a huge advantage. We now have the MR Linac which offers better soft tissue contrast, imaging before, during and after treatment and imaging of the effects and biology of treatment. The Christie is part of the Elekta MR-Linac consortium that is now global and has grown considerably. Examples of what can be done with the MR Linac were shown, radiotherapy can be even further personalised e.g. to reflect daily changes to a bladder. AC noted how resource intensive it is on the MR Linac and it wouldn’t be possible to treat the volume of our patients this way, but it will be particularly helpful for some patients. AC outlined the advances relating to oxygen in tumours. A virtual tour of the department was shown to give Board an idea of what the department and the kit looks like. CE noted the complexity of the kit and the large multidisciplinary team needed, many of whom are dedicated to this service. CE outlined the challenges. The technology is very complex, and the radiation can bend the beam and vice versa. The physicists work to overcome this. Time is also a challenge as it takes longer. Real time decisions and recalculations are being made. This is also a hybrid technology & requires

2